Pharma Services March 2023

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

Highlights from this edition:

• CROMSOURCE was acquired by ClinChoice
• Trans Genic Inc. (TSE:2342) announced its acquisition of MASC Co., Ltd.
• Byteflies NV has closed a $4.8MM Series A Financing, led by Sensinnovat bvba